Two hundred and ten nuclear medicine physicians, radiologists, and hematologists from 26 countries attended the 6th International Workshop on Positron Emission Tomography (PET) in Lymphoma and Myeloma held in Menton, France, in September 2016. The meeting was under the auspices of the European Lymphoma Institute (ELI), the European Association of Nuclear Medicine (EANM) the Lymphoma Study Association (LYSA), the Italian Foundation on Lymphoma (FIL) and the Carnot Institute for Lymphoma (CALYM). Forty scientific posters were presented. For the first time, specialists in the field of multiple myeloma (MM) were involved in the expert session. The aim was to establish from the experience of Italian and French studies new guidelines of FDG-PET/CT reporting for myeloma staging and restaging. The meeting dedicated an entire session to MM imaging followed by a session on the role of PET in Peripheral T cell Lymphoma. An entire session addressed the issues of Deauville scale particularly for end treatment assessment and the challenging consequences of immunomodulatory treatments on PET reporting. A specific session presented the potential role of baseline metabolic tumor measurement to predict outcome and identify different risk categories and the main results obtained in different lymphoma entities were described. Whether it could replace clinical staging has been extensively discussed. The more recent results obtained in the H10 trial have been presented and compared to the published data in early stage Hodgkin lymphoma. Finally, the ongoing studies using PET for guiding therapeutic strategies have been reported by the various lymphoma cooperative groups that participated to the meeting.

Report of the 6th International Workshop on PET in lymphoma / Nanni, Cristina; Cottereau, Anne Ségolène; Lopci, Egesta; Bodet-Milin, Caroline; Coronado, Monica; Pro, Barbara; Kim, Wong Seog; Trotman, Judith; Barrington, Sally; Duhrsen, Ulrich; Vander Borght, Thierry; Zamagni, Elena; Kraeber-Bodéré, Françoise; Messiou, Christina; Rahmouni, Alain; Buvat, Irène; Andre, Marc; Hertzberg, Mark; Oyen, Wim; Casasnovas, Olivier; Luminari, Stefano; Garderet, Laurent; Montravers, Françoise; Kobe, Carsten; Kluge, Regine; Versari, Annibale; Zucca, Emanuele; Moreau, Philippe; Cheson, Bruce; Haioun, Corinne; Gallamini, Andrea; Meignan, Michel. - In: LEUKEMIA & LYMPHOMA. - ISSN 1042-8194. - 58:10(2017), pp. 2298-2303. [10.1080/10428194.2017.1298752]

Report of the 6th International Workshop on PET in lymphoma

Luminari, Stefano
Writing – Review & Editing
;
2017

Abstract

Two hundred and ten nuclear medicine physicians, radiologists, and hematologists from 26 countries attended the 6th International Workshop on Positron Emission Tomography (PET) in Lymphoma and Myeloma held in Menton, France, in September 2016. The meeting was under the auspices of the European Lymphoma Institute (ELI), the European Association of Nuclear Medicine (EANM) the Lymphoma Study Association (LYSA), the Italian Foundation on Lymphoma (FIL) and the Carnot Institute for Lymphoma (CALYM). Forty scientific posters were presented. For the first time, specialists in the field of multiple myeloma (MM) were involved in the expert session. The aim was to establish from the experience of Italian and French studies new guidelines of FDG-PET/CT reporting for myeloma staging and restaging. The meeting dedicated an entire session to MM imaging followed by a session on the role of PET in Peripheral T cell Lymphoma. An entire session addressed the issues of Deauville scale particularly for end treatment assessment and the challenging consequences of immunomodulatory treatments on PET reporting. A specific session presented the potential role of baseline metabolic tumor measurement to predict outcome and identify different risk categories and the main results obtained in different lymphoma entities were described. Whether it could replace clinical staging has been extensively discussed. The more recent results obtained in the H10 trial have been presented and compared to the published data in early stage Hodgkin lymphoma. Finally, the ongoing studies using PET for guiding therapeutic strategies have been reported by the various lymphoma cooperative groups that participated to the meeting.
2017
7-mar-2017
58
10
2298
2303
Report of the 6th International Workshop on PET in lymphoma / Nanni, Cristina; Cottereau, Anne Ségolène; Lopci, Egesta; Bodet-Milin, Caroline; Coronado, Monica; Pro, Barbara; Kim, Wong Seog; Trotman, Judith; Barrington, Sally; Duhrsen, Ulrich; Vander Borght, Thierry; Zamagni, Elena; Kraeber-Bodéré, Françoise; Messiou, Christina; Rahmouni, Alain; Buvat, Irène; Andre, Marc; Hertzberg, Mark; Oyen, Wim; Casasnovas, Olivier; Luminari, Stefano; Garderet, Laurent; Montravers, Françoise; Kobe, Carsten; Kluge, Regine; Versari, Annibale; Zucca, Emanuele; Moreau, Philippe; Cheson, Bruce; Haioun, Corinne; Gallamini, Andrea; Meignan, Michel. - In: LEUKEMIA & LYMPHOMA. - ISSN 1042-8194. - 58:10(2017), pp. 2298-2303. [10.1080/10428194.2017.1298752]
Nanni, Cristina; Cottereau, Anne Ségolène; Lopci, Egesta; Bodet-Milin, Caroline; Coronado, Monica; Pro, Barbara; Kim, Wong Seog; Trotman, Judith; Barrington, Sally; Duhrsen, Ulrich; Vander Borght, Thierry; Zamagni, Elena; Kraeber-Bodéré, Françoise; Messiou, Christina; Rahmouni, Alain; Buvat, Irène; Andre, Marc; Hertzberg, Mark; Oyen, Wim; Casasnovas, Olivier; Luminari, Stefano; Garderet, Laurent; Montravers, Françoise; Kobe, Carsten; Kluge, Regine; Versari, Annibale; Zucca, Emanuele; Moreau, Philippe; Cheson, Bruce; Haioun, Corinne; Gallamini, Andrea; Meignan, Michel
File in questo prodotto:
File Dimensione Formato  
nanni2017.pdf

Accesso riservato

Tipologia: Versione pubblicata dall'editore
Dimensione 783.69 kB
Formato Adobe PDF
783.69 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1153070
Citazioni
  • ???jsp.display-item.citation.pmc??? 8
  • Scopus 21
  • ???jsp.display-item.citation.isi??? 21
social impact